Veerhealth Care P/B Ratio
Veerhealth Care (VEERHEALTH) P/B ratio is 4.35 (High), book value per share ₹11.50 vs Healthcare average P/B of -0.01 — Very High - Significant premium, high growth expectations or speculative. For live price, earnings yield and the full fundamental profile, see VEERHEALTH share price.
Current Valuation Metrics
Book Value Breakdown (2026)
Valuation Signal
Sector Context
VEERHEALTH P/B Ratio — Valuation Insights & Book Value Analysis
Veerhealth Care price-to-book ratio interpretation, valuation status and historical context — current P/B 4.35 (High). Explore VEERHEALTH value investing to estimate fundamental worth using multiple valuation models.
- Stock appears overvalued with PB of 4.35, trading at significant premium to book value
- Trading at high premium to book value - indicates strong growth expectations or asset-light business model
- Current PB is 130.6% above historical average
- Trading at premium to sector average PB of -0.01
Veerhealth Care P/B Ratio Historical Trend
VEERHEALTH annual price-to-book ratio — 5 years, book value per share and year-end price. P/B below 1.0 indicates the stock trades below net asset value. Read VEERHEALTH ex-dividend dates for the complete payout history and dividend yield track record.
VEERHEALTH Historical P/B Ratio — Book Value Per Share & Year-End Price
Veerhealth Care annual P/B ratio, book value per share (₹), year-end price and total equity in ₹ Crores.
| Year | P/B Ratio | Book Value/Share (₹) | Year-end Price (₹) | Total Equity (₹ Cr) | Valuation |
|---|---|---|---|---|---|
| 2026 | 4.35 | ₹11.5 | ₹49.99 | ₹23 | High |
| 2025 | 1.76 | ₹11.0 | ₹19.33 | ₹22 | Moderate |
| 2024 | 1.77 | ₹11.0 | ₹19.52 | ₹22 | Moderate |
| 2023 | 0.97 | ₹21.0 | ₹20.38 | ₹21 | Low |
| 2022 | 0.58 | ₹20.0 | ₹11.58 | ₹14 | Low |
VEERHEALTH vs Healthcare Peers — P/B Ratio Comparison
Veerhealth Care P/B 4.35 vs Healthcare average -0.01, median 0.62 — range -6.55–1.09.
| Company | Symbol | P/B Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Parmax Pharma | PARMAX | -6.55 | ₹46 | Low |
| Span Divergent | SDL | -6.32 | ₹19 | Low |
| Oxygenta Pharmaceutical | OXYGENTAPH | -5.54 | ₹203 | Low |
| Satiate Agri | SATAGRI | -3.39 | ₹8 | Low |
| Adline Chem Lab | ADLINE | -3.03 | ₹5 | Low |
| Bharat Immunologicals | BIBCL | -2.0 | ₹65 | Low |
| Krebs Biochemicals & Ind… | KREBSBIO | -0.82 | ₹129 | Low |
| Cresanto Global | CRESANTO | -0.7 | ₹2 | Low |
| Vivimed Labs | VIVIMEDLAB | -0.21 | ₹50 | Low |
| Triochem Products | TRIPR | 0.04 | ₹0 | Low |